RNCR3 Knockdown Inhibits Diabetes Mellitus-Induced Retinal Reactive Gliosis.

Chang Liu,Chao-Peng Li,Jia-Jian Wang,Kun Shan,Xin Liu,Biao Yan
DOI: https://doi.org/10.1016/j.bbrc.2016.09.032
IF: 3.1
2016-01-01
Biochemical and Biophysical Research Communications
Abstract:Retinal reactive gliosis is an important pathological feature of diabetic retinopathy. Identifying the underlying mechanisms causing reactive gliosis will be important for developing new therapeutic strategies for treating diabetic retinopathy. Herein, we show that long noncoding RNA-RNCR3 knockdown significantly inhibits retinal reactive gliosis. RNCR3 knockdown leads to a marked reduction in the release of several cytokines. RNCR3 knockdown alleviates diabetes mellitus-induced retinal neurodegeneration, as shown by less apoptotic retinal cells and ameliorative visual function. RNCR3 knockdown could also decrease Müller glial cell viability and proliferation, and reduce the expression of glial reactivity-related genes including GFAP and vimentin in vitro. Collectively, this study shows that RNCR3 knockdown may be a promising strategy for the prevention of diabetes mellitus-induced retinal neurodegeneration.
What problem does this paper attempt to address?